Stephen Nicholls

Trials

Studies that name Stephen Nicholls as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:47 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07428473 · A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

  Monash University · recruiting · Elevated LDL-C and High Cholesterol · study chair
• N/A
  NCT05834673 · VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

  Monash University · terminated · Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Heart Disease (CHD), Cerebrovascular Disease · principal investigator
• N/A
  NCT05521542 · Advanced NanoTherapies Dual-API DCB to Treat De-Novo Lesions in Patients With Symptomatic Coronary Artery Disease

  Advanced NanoTherapies · active not recruiting · Coronary Artery Disease · study director
• N/A
  NCT05325034 · Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

  Stephen Nicholls · recruiting · Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis · principal investigator
• Ph1/Ph2
  NCT02678923 · MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial

  The Medicines Company · completed · Acute Coronary Syndrome · principal investigator
• Ph2
  NCT02484378 · CER-001 Atherosclerosis Regression ACS Trial

  Cerenis Therapeutics, SA · completed · Acute Coronary Syndromes · study chair
• Ph3
  NCT02298088 · Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

  Hospital do Coracao · completed · Acute ST Segment Elevation Myocardial Infarction, Thrombolysis in Myocardial Infarction Flow · study chair
• Ph3
  NCT02104817 · Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

  AstraZeneca · completed · Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) · principal investigator
• Ph2
  NCT01067820 · ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation

  Resverlogix Corp · completed · Coronary Artery Disease · principal investigator
• N/A
  NCT00912236 · Evaluation of High-Density Lipoprotein in Obesity Study

  The Cleveland Clinic · terminated · Obesity · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.